These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2019-001431-31 A Phase 2 Study Assessing the Safety and Efficacy of AT-527 in Combination with Daclatasvir in Subjects with Chronic HCV Infection 2020-03-18 due-trials
Exempt 2019-004997-24 A Phase I/IIa Study Assessing AT-777 in Healthy Subjects and AT-777 in Combination with AT-527 in HCV-Infected Subjects 2022-01-07 not-yet-due
Reported results Terminated 2020-002869-34 A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-527 in Subjects with Moderate COVID-19 2022-01-06 due-trials
Other 2022-003268-25 A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 not-yet-due
Ongoing 2023-000160-54 PHASE 2, OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFICACY OF BEMNIFOSBUVIR (BEM) AND RUZASVIR (RZR) IN SUBJECTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION Un studiu de faza 2, deschis, pentru... not-yet-due